One Health approach to use of veterinary pharmaceuticals
Loading...
Date
Authors
Margalida, Antoni
Bogliani, G.
Bowden, Christopher G.R.
Donázar, J.A.
Genero, F.
Gilbert, Martin
Karesh, W.B.
Kock, Richard A.
Lubroth, J.
Manteca, X.
Journal Title
Journal ISSN
Volume Title
Publisher
American Association for the Advancement of Science
Abstract
An estimated 6051 tons of active substances went into the
production of veterinary pharmaceuticals (VPs) for the
treatment of food animals in the European Union (EU) in
2004, including 5393 tons of antibiotics and 194 tons of antiparasitics
(1). With global meat production projected to
increase (2) and the growing market for companion animal
pharmaceuticals (3), t he u se o f VPs w ill c ontinue t o i ncrease.
Although VPs may benefit the health and welfare of
domestic animals and the efficiency of food animal production,
they can contaminate the environment through manufacturing,
treatment of animals, and disposal of carcasses,
offal, urine, feces, and unused products (4) (see the chart).
This contamination is a threat to nontarget species, including
humans. With Spain having recently authorized marketing
of a V P t hat w as b anned i n S outh A sia i n t he p ast
decade in light of environmental impacts, we recommend
strengthening of current procedures and addition of a more
proactive, holistic, One Health approach applicable to all
VPs.
Description
Keywords
Veterinary pharmaceuticals, Treatment of animals, Disposal of carcasses
Sustainable Development Goals
Citation
Margalida, A, Bogliani, G, Bowden, CGR, Donázar, JA, Genero, F, Gilbert, M, Karesh, WB, Kock, R, Lubroth, J, Manteca, X, Naidoo, V, Neimanis, A, Sánchez-Zapata, JA, Taggart, MA, Vaarten, J, Yon, L, Kuiken, T & Green, RE 2014, 'One Health approach to use of veterinary pharmaceuticals', Science, vol. 346, no. 6215, pp. 1296-1298.